The Global Fund to Fight AIDS, Tuberculosis and Malaria praises Japan for its outstanding leadership in global health with a strong commitment of up to US$1.08 billion to help end the three diseases by 2030 and build stronger and more resilient and s...
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$989,687 in emergency funding to cover the gap of urgently needed health commodities for the treatment and prevention of HIV, including antiretrovirals, rapid tests, viral load te...
Today the Global Fund to Fight AIDS, TB and Malaria is announcing a crucial new catalytic fund to support community health workers across up to 10 African countries. The Africa Frontline First Catalytic Fund (AFF-CF) will provide financing to acceler...
The Global Fund to Fight AIDS, Tuberculosis and Malaria is deeply concerned about the slowdown of the global fight against HIV. A new UNAIDS report released this week at the International AIDS Conference in Montreal shows that progress against the di...
The Global Fund welcomes Goodbye Malaria’s renewed commitment to the fight against AIDS, tuberculosis (TB) and malaria with a new pledge of US$5.5 million (ZAR 88 million) for the Global Fund’s Seventh Replenishment.
The Global Fund to Fight AIDS, Tuberculosis and Malaria warmly welcomes today's announcement by Luxembourg of a €11.7 million pledge for the upcoming three-year period, a 30% increase in Luxembourg’s contributions to the Global Fund from the previous...
Ahead of the Global Fund’s Seventh Replenishment Conference, the Global Fund and partners called on all players in the private sector – philanthropists, foundations, and corporations – for a step-change in their commitment to ending AIDS, tuberculosi...
The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023.
The Global Fund to Fight AIDS, Tuberculosis and Malaria thanks the European Union and Team Europe for their contribution to the Global Fund's COVID-19 Response Mechanism (C19RM). The President of the European Commission, Ursula von der Leyen, announc...